Search

Search Results
Results 4601 - 4610 of 4617 for multiple sclerosis
  • Coversyl Plus
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Coversyl Plus (perindopril and indapamide) intended for persons living in Australia.
  • Prexum
    Drug - 15 Jul 2022
    Consumer Medicine Information (CMI) about Prexum (perindopril) intended for persons living in Australia.
  • Perindo
    Drug - 6 Jul 2022
    Consumer Medicine Information (CMI) about Perindo (perindopril) intended for persons living in Australia.
  • Dapa-Tabs
    Drug - 11 May 2022
    Consumer Medicine Information (CMI) about Dapa-Tabs (indapamide hemihydrate) intended for persons living in Australia.
  • Tecfidera
    Drug - 6 Oct 2021
    Consumer Medicine Information (CMI) about Tecfidera (Dimethyl fumarate) intended for persons living in Australia.
  • An Analytical and Legal Spotlight on Cannabis
    White Paper - 9 Feb 2021
    This article will look at cannabis in relation to an analytical and leag standpoint.
  • How Neurodegenerative Diseases are Affected by Gamma Synuclein Aggregation
    White Paper - 28 Jan 2020
    This article discusses gamma Synuclein aggregation in neurodegenerative diseases.
  • Metabotropic Glutamate Receptor Research Highlights
    White Paper - 6 Jun 2019
    Metabotropic glutamate receptors are exciting therapeutic targets due to their involvement in cardiovascular and neurological diseases, and their widespread expression.
  • Hexaxim
    Drug - 9 Apr 2019
    Consumer Medicine Information (CMI) about Hexaxim (Diphtheria, tetanus, pertussis , hepatitis B , poliomyelitis and Haemophilus influenzae type b conjugate vaccine) intended for...
  • Vitamin D Deficiency
    Health - 27 Feb 2019
    Rickets has been around for centuries, but its roots as a symptom of vitamin D deficiency began only in the 17th century, when Francis Glisson published his findings on the disease and proposed that...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback